Having established that si-DHRS4 inhibits glioma cell proliferation, invasion, and migration in vitro, we evaluated the growth promoting effect of DHRS4 in vivo using a subcutaneous tumorigenesis experiment. Here, DHRS4 is linked to central nervous system cancer.